3 Penny Stocks On TSX With Market Caps Below CA$2B

In This Article:

The Canadian market has experienced a pullback recently, with the TSX index declining by about 6.5% since its peak in December, amid political uncertainty and potential shifts in government leadership. Despite this volatility, long-term investors may find opportunities to explore smaller companies that offer growth potential and financial stability. Penny stocks, though an outdated term, remain relevant as they often represent emerging companies that could provide value for those willing to navigate their risks and rewards.

Top 10 Penny Stocks In Canada

Name

Share Price

Market Cap

Financial Health Rating

Findev (TSXV:FDI)

CA$0.445

CA$14.04M

★★★★★★

Mandalay Resources (TSX:MND)

CA$4.14

CA$389.72M

★★★★★★

Pulse Seismic (TSX:PSD)

CA$2.24

CA$115M

★★★★★★

Silvercorp Metals (TSX:SVM)

CA$4.32

CA$942.04M

★★★★★★

PetroTal (TSX:TAL)

CA$0.54

CA$501.61M

★★★★★★

Foraco International (TSX:FAR)

CA$2.28

CA$221.48M

★★★★★☆

East West Petroleum (TSXV:EW)

CA$0.04

CA$3.62M

★★★★★★

NamSys (TSXV:CTZ)

CA$1.25

CA$33.58M

★★★★★★

Hemisphere Energy (TSXV:HME)

CA$1.80

CA$179.46M

★★★★★☆

Enterprise Group (TSX:E)

CA$1.85

CA$112.03M

★★★★☆☆

Click here to see the full list of 956 stocks from our TSX Penny Stocks screener.

Let's explore several standout options from the results in the screener.

Cronos Group

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Cronos Group Inc. is a cannabinoid company involved in the cultivation, production, and marketing of cannabis products across Canada, Israel, and Germany with a market cap of CA$1.07 billion.

Operations: The company generates revenue of $111.23 million from its operations in cultivating, manufacturing, and marketing cannabis and cannabis-derived products.

Market Cap: CA$1.07B

Cronos Group Inc., despite being unprofitable, has shown promising revenue growth, with third-quarter 2024 revenue increasing to US$34.26 million from US$24.81 million a year ago and achieving a net income of US$8.35 million compared to a loss previously. The company reported significant impairment charges on long-lived assets, impacting financial results. With no debt and substantial short-term assets exceeding liabilities, Cronos maintains financial stability. However, an inexperienced board and ongoing profitability challenges remain concerns for investors in the volatile penny stock market segment in Canada’s cannabis industry.

TSX:CRON Financial Position Analysis as at Dec 2024
TSX:CRON Financial Position Analysis as at Dec 2024

Lavras Gold

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Lavras Gold Corp. is involved in the exploration and development of mineral resource properties in Brazil, with a market cap of CA$113 million.